Precision BioSciences Inc (DTIL)
10.52
-0.32
(-2.95%)
USD |
NASDAQ |
May 03, 16:00
10.38
-0.14
(-1.38%)
After-Hours: 20:00
Precision BioSciences Accounts Payable (Quarterly): 2.968M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.968M |
September 30, 2023 | 0.531M |
June 30, 2023 | 0.781M |
March 31, 2023 | 0.701M |
December 31, 2022 | 0.653M |
September 30, 2022 | 1.061M |
June 30, 2022 | 0.797M |
March 31, 2022 | 0.699M |
December 31, 2021 | 1.144M |
September 30, 2021 | 0.486M |
June 30, 2021 | 0.478M |
Date | Value |
---|---|
March 31, 2021 | 0.445M |
December 31, 2020 | 0.792M |
September 30, 2020 | 0.959M |
June 30, 2020 | 1.587M |
March 31, 2020 | 1.766M |
December 31, 2019 | 2.037M |
September 30, 2019 | 4.465M |
June 30, 2019 | 2.882M |
March 31, 2019 | 5.057M |
December 31, 2018 | 2.218M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.445M
Minimum
Mar 2021
4.465M
Maximum
Sep 2019
1.328M
Average
0.797M
Median
Jun 2022
Accounts Payable (Quarterly) Benchmarks
Altimmune Inc | 2.07M |
BioVie Inc | -- |
Adial Pharmaceuticals Inc | 0.1033M |
Gritstone Bio Inc | 3.819M |
Humacyte Inc | 6.49M |